Introduction
============

ICU admission of patients with lung cancer remains debated because of the poor short-term prognosis. We evaluated the duration of survival of patients admitted to our ICU and looked for factors associated with better survival.

Methods
=======

All patients with nonresectable lung cancer admitted to our ICU between 1 January 2008 and 31 December 2010 were included in a retrospective study. Postoperative patients were not included.

Results
=======

Twenty-two patients were included. Seventeen had nonsmallcell lung cancer (NSCLC). One had small cell lung cancer. Fifteen patients (65%) had metastatic disease. Twelve patients were in palliative therapy. The reason for ICU admission was acute respiratory failure in 12 patients (55%), hemorrhage in five patients (23%). Nine patients (41%) had an infection. Fourteen patients (64%) needed invasive mechanical ventilation. One-month survival was 45% (10/22). Six-month survival was 13% (3/22). One-year survival was 0%. One-month survivors showed a nonsignificant trend to lower performance status and severity of disease. All 6-month survivors had metastatic disease. Six-month survivors had nonsignificantly lower performance status (1.7 ± 0.6 vs. 2.7 ± 1.2; *P =*NS). IGS II, SOFA score and duration of mechanical ventilation were significantly shorter in survivors (see Table [1](#T1){ref-type="table"}).

                      IGS          SOFA         Number of ventilation days
  ------------------- ------------ ------------ ----------------------------
  Nonsurvivors        53.2 ± 6.5   5.6 ± 3.8    6.1 ± 6.4
  6-month survivors   36.3 ± 9.8   1.3 ± 2.3    0.7 ± 1.2
                      *P*\< 0.05   *P*\< 0.05   *P*\< 0.01

Conclusion
==========

Prognosis of patients with nonresectable lung cancer admitted to the ICU was poor. Metastatic disease did not influence survival in our survey. Patients admitted for a critical illness requiring more than a few days of mechanical ventilation were very unlikely to survive over 6 months.
